TP53 and cancer: By demonstrating that GOF phenotypes only manifest in aneuploid cells, the study suggests that previous interpretations attributing oncogenic properties solely to mutant p53 may need reevaluation and reinforces the idea that chromosomal alterations play a crucial role in determining cancer phenotypes [79].